Archives: Agenda

• New generation of instruments securing the quality of your beverage
• Modular setup for maximum flexibility when measuring Brix, CO2, O2, Colour, Viscosity, pH, optical Rotation or Alcohol
• Controlling the quality not only in the lab but also inline for fast results, minimum down time and zero waste
• Instruments and beyond, Automatization and Software solutions to support your efficiency while keeping the quality high

• Low and no alcohol is more complex than soft drinksThe Wine and Spirit Trade Association has become a leader in helping to advise drink producers on how to label and market no and low products. Last year we published the UK’s first no and low alcohol guides in a bid to clear up confusion on how to communicate to consumers what they are purchasing and promote these products in a socially responsible way.The focus of this session is to help you understand the innovative world of no and low and what to watch out for if you are thinking of producing alcohol alternatives.
  • What is an alcohol alternative?
  • Labelling and marketing rules – aren’t they the same as for a soft drink?
  • Health and nutrition claims – would these help or hinder innovation?

• Impact on our drinking habits
• Growth opportunities this represents for the non-alcoholic beverage industry

• Is pulp really the future – Can it scale? Can it be cost effective? Can it be premium?
• Do your consumers understand sustainability? And how can we help?

• Role that Sustainability plays in the Lipton brand
• Making products sustainable by design: introducing Lipton Sustainability agenda
• Key initiatives + progress made
• What the future holds
• Learnings

• New regulations and guidance around clinical trials in the US: how will this impact you?
• Staff turnover and layoffs: handling changes in the industry in order to ensure success
• Navigating the constantly evolving vendor and CRO landscape as a small to mid sized sponsor company
• An overview of technology and innovation in the clinical trial industry: what’s working and what isn’t?

• How AI can improve and streamline clinical operations: opportunities and real use cases
• AI as a tool to support thinly stretched clinical operations teams: where can this be utilized to minimize workloads and increase overall output?
• How are clinical trial sponsors implementing tools such as Generative AI and ChatGPT?
• Regulatory and ethical considerations on AI in clinical trials: are there limitations to its use?